ENTITY

China Resources Dubl Crne Phrmctl (600062 CH)

24
Analysis
Health CareChina
China Resources Double-Crane Pharmaceutical Co., Ltd. develops, manufactures and markets a variety of medical products. The Company's products include anti-influenza, antihypertensives, and antibiotics.
more
07 Aug 2024 09:48

China Resources Beverage Pre-IPO - Peer Comparison - Middling

China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO. We have looked at the company's past performance in our previous...

Logo
304 Views
Share
bullishOneness Biotech
23 Jul 2024 09:30

Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream

​Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...

Logo
318 Views
Share
bullishTencent
04 May 2024 00:35

Upgrading Emerging Markets to Market Weight; China/Hong Kong Continue to Bottom; Energy Breakdowns

Upgrading Emerging Markets $EEM $VWO to Market Weight; China/Hong Kong Continue to Bottom $FXI $MCHI $KWEB; Lows Likely in on $ACWI; Commodities...

Logo
448 Views
Share
30 Apr 2024 09:54

China Resources Beverage Pre-IPO - The Positives - Strong Position in Its Main Market

China Resources Beverage is looking to raise US$1bn in its upcoming Hong Kong IPO. In this ntoe, we talk about the positive aspects of the deal.

Logo
420 Views
Share
25 Apr 2024 10:10

China Resources Beverage (Holdings) Pre-IPO Tearsheet

China Resources Beverage (Holdings) Company Limited is looking to raise US$1bn in its upcoming Hong Kong IPO. The bookrunners on the deal are BofA,...

Logo
483 Views
Share
x